Inflammation and bone metabolism in rheumatoid arthritis. Pathogenetic aspects and therapeutic options;ENTZUNDUNG UND KNOCHEN-STOFFWECHSEL BEI RHEUMATOIDER ARTHRITIS

Medizinische Klinik

Volumn 92, Issue 10, 1997, Pages 607-614

  Oelzner, Peter ^a,b   Hein, Gert ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Funktionsbereich Rheumatologie und Osteologie   (Germany)

Author keywords

Bone metabolism; Inflammation; Proinflammatory cytokines; Rheumatoid arthritis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; NITRIC OXIDE; VITAMIN D; AUTACOID; GLUCOCORTICOID;

BONE METABOLISM; CHRONIC INFLAMMATION; DISEASE ACTIVITY; HUMAN; OSTEOPOROSIS; REVIEW; RHEUMATOID ARTHRITIS; BONE DENSITY; METABOLISM; OSTEOBLAST; OSTEOCLAST; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ARTHRITIS, RHEUMATOID; BONE DENSITY; CYTOKINES; GLUCOCORTICOIDS; HUMANS; INFLAMMATION MEDIATORS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; RISK FACTORS; VITAMIN D;

EID: 0030780215     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044788     Document Type: Review

References (54)

1. Abendroth, K.: The mechanoreceptor for remodeling and the influence of fluoride therapy for osteoporosis on it. In: Regling, G. (ed.): Wollfs law and connective tissue regulation. de Gruyter, Berlin - New York 1992, S. 199-202.
2. Aota, S., T. Nakamura, K. Suzuki, Y. Tanaka, Y Okazaki, Y. Segawa, M. Miura, S Kikuchi: Effects of indomethazin administration on bone turnover and bone mass in adjuvant arthritis in rats. Calcif. Tiss. int. 59 (1996), 385-391.
3. Bamberger, C M., H. M. Schulte: Wirkungsmechanismus der Glukokortikoide. Internist (Berl.) 38 (1997), 366-370.
4. Bellido, T., N. Stahl, T. J. Farruggella, V. Borba, G. D. Yancopoulos, S. C. Manolagas: Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J. clin. Invest. 97 (1996), 431-437
5. Bouillon, R., W. H. Okamura, A. W. Norman: Structure-function relationships in the vitamin D endocrine system. Endocr. Rev.16 (1995) 200-257.
6. Chilron, K. M., R. G. G. Russell, M. J. Rogers: Bisphosphonate-induced apoptosis in J774 macrophages is associated with cell cycle arrest and decreased levels of bcl-2. Bone 20, Suppl. (1997), 113S.
7. Civitelli, R.: The role of vitamin D metabolites in the treatment of osteoporosis. Calcif. Tiss. int. 57 (1995), 409-414.
8. Compston, J. E , S Vedi, P. I Croucher, N. J. Garrahan, M. M. O. Sullivan: Bone turnover in non-steroid treated rheumatoid arthritis. Ann. rheum. Dis. 53 (1994), 1263-1266.
9. Da Silva, J. A. P.: Sex hormones, glucocorticoids and autoimmunity: facts and hypothesis. Ann. rheum. Dis. 54 (1995), 6-16.
10. Deodhar, A. A., A. D. Woolf: Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Brit. J. Rheum. 35 (1996), 309-322.
11. Dequeker, J., K. Maenaut, J. Verwilghen, R. Westhovens: Osteoporosis in rheumatoid arthritis. Clin. exp. Rheum., Suppl. 12 (1995), S21-26.
12. Eggelmeijer, F., S. E. Papapoulos, H. C. van Paassen, B. A. Dijkmans, R. Valkema, M. L. Westedt, J. O. Landman, E K. Pauwels, F. C. Breedveld: Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthr. and Rheum. 39 (1996), 396-402.
13. Ekenstam, E : Influence of inflammation and corticosteroid treatment on indices of bone turnover and parathyroid function. Scand. J. Rheum. 20 (1991), 220.
14. Frost, H. M.: The role of changes in mechanical usage set points in the pathogenesis of osteoporosis. J. Bone Miner. Res. 7 (1992), 253-261.
15. Gough, A. K., J. Lilley, S Eyre, R. L. Holder, P. Emery: Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344 (1994), 23-27.
16. Gough, A. K., N. F. Peel, R. Eastell, R. L. Holder, J. Lilley, P. Emery: Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann. rheum. Dis. 53 (1994), 14-17.
17. Hahn, G., B. Stuhlmuller, N. Hain, J. R. Kalden, K. Pfizenmaier, G. R. Burmester: Modulation of monocyte activation in patients with rheumatoid arthritis by leukaperesis therapy. J. clin. Invest. 91 (1993), 862-870.
18. Hillman, L., J T. Cassidy, L. Johnson, D. Lee, S. H. Allen Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J. Pediat. 124 (1994), 910-916.
19. Hirohata, S., T. Yanagida, K. Itoh, H. Nakamura, S. Yoshino, T. Tomita, T. Ochi: Accelerated generation of CD14+ monocyte-lineage cells from the bone marrow of rheumatoid arthritis patients. Arthr. and Rheum 39 (1996), 836-843.
20. Hooyman, J. R., L. J Melton, A. M Nelson, W. M. O Fallon, B. L. Riggs. Fractures after rheumatoid arthrítis: A population based study. Arthr. and Rheum. 27 (1984), 1353-1361.
21. Hukkanen, M., F. J. Hughes, L. D. Buttery, S. S. Gross, T. J. Evans, S. Seddon, V. Riveros-Moreno, I. Macintyre, J. M. Polak: Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136 (1995), 5445-5453.
22. Kim, G . C. Choi, E. Kim, J. Park, K. U Lee: Involvement of different second messengers in PTH- and IL-1 stimulated IL-6 production in human bone marrow stromal cells. Osteoporos. int. 6, Suppl. 1 (1996), S100.
23. Kose, K. N., J. F Xie, D. L. Carnes, D T. Graves: Proinflammatory cytokines downregulate platelet derived growth factor-alpha receptor gene expression in human osteoblastic cells. J. cell. Physiol. 166 (1996), 188-197.
24. Kroger, H., I. Arnala, V. Rehnberg, M. Hamalainen, E. Alhava: Histomorphometry of periarticular bone in rheumatoid arthritis. Ann. Chir. Gynaec. 83 (1994), 56-62.
25. Kröger, H., I. M. Penttilä, E. M. Alhava: Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand. J. Rheum. 22 (1993), 172-177.
26. Kuroki, T., M. Shingu, Y. Koshihara, M Nobunaga: Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Brit. J. Rheum. 33 (1994), 224-230.
27. Laan, R. F. J. M., W. C. A. M. Buijs, A. L. M. Verbeek: Bone mineral density in patients with recent onset rheumatoid arthritis. influence of disease activity and functional capacity Ann. rheum. Dis. 52 (1993), 21-26.
28. Langman, C. B., K. K. Ford, L. M. Pachman, F. Glorieux: Vitamin D metabolism in rats with adjuvant induced arthritis. J. Bone Miner. Res. 5 (1990), 905-913.
29. Manolagas, S. C., R. L. Jilka: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis: New Engl. J. Med. 332 (1995), 305-311.
30. Mateo, L., J. M. Nolla, M. R. Bonnin, M. A. Navarro, D. Roig-Escofet: Sex hormone status and bone mineral density in men with rheumatoid arthritis. J. Rheum 22 (1995), 1455-1460.
31. Mayur, N., S. Lewis, B. D Catherwood, M. S. Nanes: Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells. J. Bone Miner. Res. 8 (1993), 997-1003.
32. McGill, P. E., H. Kerr, A. Stirling: Effect of cyclical etidronate on BMD in steroid treated RA. Bone 20, Suppl. (1997), S99.
33. Michel, B.A., D.A. Bloch, J.F. Fries: Predictors of fractures in early rheumtoid arthritis. J. Rheumatol. 18 (1991), 804-808.
34. Michel, B. A., D. A. Bloch, F. Wolfe, J. F. Fries: Fractures in rheumatoid arthritis. an evaluation of associated risk factors. J. Rheum. 20 (1993), 1666-1669.
35. Mönkkönen, J., T. D. Heath: The effects of liposome-encapsulated and free clodronate on the growth of macropage-like cells in vitro: the role of calcium and iron. Calcif. Tiss. int. 53 (1995), 139-146.
36. Nguyen, L., F. E. Dewhirst, P. V. Hauschka, P. Stashenko: Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res. 10 (1991), 15-21.
37. Oelzner, P., R. Brauer, B. Wünsche, I. Schütz, R. W. Kinne, K. Thoß, K. Abendroth, G. Hein, G. Stein: Treatment of osteopenia in rat antigen induced arthritis with clodronate-liposomes. Osteoporos. int. 6, Suppl. 1 (1996) S250.
38. Oelzner, P., A. Muller, T. Eidner, K Abendroth, G. Hein, G. Stein: Relationship between disease activity and serum levels of 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and PTH in patients with rheumatoid arthritis. Osteoporos. int. 6, Suppl. 1 (1996), S276.
39. Oelzner, P., S. Franke, A. Müller, F. Deschner, K. Abendroth, G Hein, A. Hüller, G Stein: Correlation between serum levels of calcium-regulating hormones and soluble markers of immune activation in patients with rheumatoid arthritis. Bone 20, Suppl (1997), 89S
40. Pacifici, R.: Cytokines and osteoclast activity. Calcif. Tiss. int. 56, Suppl 1 (1995), S27-28.
41. Peel, N. F., D. J. Moore, N. A. Barrington, D. E. Bax, R. Eastell: Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann. rheum. Dis 54 (1995). 801-806.
42. Pennanen, N., T. Nissinen, S. Lapinjoki, A. Urrti, J. Mönkkönen: The effect of liposome encapsulated and free bisphosphonates on IL-Iß, IL-6, TNF alpha secretion from macrophages. Bone Miner. Res. 25 (1994), S67.
43. Pepmueller, P. H., J. T. Cassidy, S. H. Allen, L. S. Hillman: Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthr. and Rheum. 39 (1996), 746-757.
44. Ralston, S. H.: Nitric oxide and bone. Bone 20, Suppl. (1997), 3S.
45. Ringe, J. D.: Generalisierte Osteoporose bei chronischer Polyarthritis - Pathomechanismen und Behandlungs-ansätze. Z. Rheum. 55 (1996), 149-157.
46. Romas, E., N. Udagawa, H. Zhou, T. Tamura, M. Saito, T. Taga, D. J. Hilton, T. Suda, K. W. Ng, T. J. Martin: The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. exp. Med. 183 (1996), 2581-2591.
47. Sambrook, P., J. Birmingham, P Kelly, S. Kempler, T. Nguyen, N. Pocock, J. Eisman: Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol and calcitonin. New Engl. J. Med. 328 (1993), 1747-1752.
48. Sambrook, P, N., J. Jones: Corticosteroid osteoporosis. Brit. J. Rheum. 34 (1995), 8-12.
49. Shimizu, S., S. Shiozawa, K. Shiozawa, S. Imura, T. Fujita: Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthr. and Rheum. 28 (1985), 25-23.
50. Udagawa, N., N. Takahashi, T. Katagiri, T. Tamura, S. Wada, D. M Findlay, T. J. Martin, H. Hirota, T. Taga, T. Kishimoto: Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. exp. Med. 182 (1995), 1461-1468.
51. Verstraeten, A., J. Dequeker, J. Nijs, P. Geusens: Prevention of postmenopausal bone loss in rheumatoid arthritis patients. A two year prospective study. Clin. exp. Rheum. 7 (1989), 351-358.
52. Zheng, S. X., V. Geenen, Y. Vrindts, M. Lopez, D. De Groote, P. F. Zangerle, J. Collette, J. Y. Reginster: Increase in IL-1β, IL-6 and TNF alpha production in postmenopausal osteoporosis. Osteoporos. int. 6, Suppl. 1 (1996), S101.
53. Zhu, J. F., A J. Valente, J. A. Lorenzo, D. Carnes, D. T. Graves. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J. Bone Miner. Res. 9 (1994), 1123-1130.
54. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthr. and Rheum. 39 (1996), 1791-1801.